Sue E. Knoblaugh
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
118
Citations
3,516
Est. group size
~12
Recurring co-author estimate
Active years
25
Publishing since 2002
Sue E. Knoblaugh works in veterinary and comparative pathology, using animal models (such as mice and dogs) to study cancer and other diseases. Her work includes developing and validating mouse models of tumors like medulloblastoma (a type of brain cancer) and prostate cancer, testing imaging tools to detect tumors during surgery, and examining metabolic conditions like diabetes linked to mitochondrial dysfunction in insulin-producing cells. She also contributes to discussions on training and credentialing in veterinary pathology as a profession.
Publication output was relatively steady and modest from 2017–2022 (3–6 per year) but rose sharply in 2023 with a large batch of related supplementary materials, followed by a decline in 2024–2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Belonging
2025
- <sup>211</sup>At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation
Journal of Nuclear Medicine · 2024
- Mitochondrial diabetes in mice expressing a dominant-negative allele of nuclear respiratory factor-1 (Nrf1) in pancreatic β-cells
Biochemical and Biophysical Research Communications · 2024
- Letters or not, here we come! A communal perspective on credentials needed for a productive career in veterinary pathology
Veterinary Pathology · 2024
- Mitochondrial diabetes in mice expressing a dominant-negative allele of nuclear respiratory factor-1 ( <i>Nrf1</i> ) in pancreatic β-cells
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Supplemental Figure S2 from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Data from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Supplemental Figure S1 from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Data from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Supplemental Figure Legends from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Supplemental Figure Legends from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Supplemental Figure S2 from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Supplemental Figure S1 from Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
2023
- Data from Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium
2023
- Data from The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread
2023
- Cancer Research×7
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Elsevier eBooks×3
- Proceedings of the National Academy of Sciences×2
- Journal of the American Veterinary Medical Association×2
- Daniel Bachmann
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yurong Lu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Daniel R. Boué
Medicine · The Ohio State University
- Jignesh Tailor
Medicine · Indiana University
- Fernando M. Núñez
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile